Michael W. Deininger

机构：University of Michigan, Michigan Medicine, Versiti Blood Center of Wisconsin · ORCID：0000-0002-2987-1331

发表论文 864 篇 · 总被引 51003 次 · h-index 99

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 133)
• Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy (2024 · Blood Advances · 被引 36)
• Novel treatment strategies for chronic myeloid leukemia (2024 · Blood · 被引 20)
• BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias? (2024 · Leukemia · 被引 17)
• Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial (2025 · Blood Cancer Journal · 被引 11)
• 5-Year Follow-up of the Phase 2 Optic Study in Patients with Chronic-Phase Chronic Myeloid Leukemia: Efficacy, Safety, and First End-of-Treatment Mutational Results (2024 · Blood · 被引 4)